Skip to main content

Table 1 Comparisons between subjects with and without aspirin therapy

From: Effects of low-dose aspirin in subjects with dyslipidemia

Variables With aspirin (n = 138) Without aspirin (n = 64)
Male (%) 72 (52.3) 33 (51.7)
Age (years) 53.2 ± 8.4 51.7 ± 6.9
Smoking (%) 66 (47.8) 30 (46.9)
SBP (mmHg) 135.7 ± 17.4 131.3 ± 12.8
DBP (mmHg) 71.4 ± 10.3 70.6 ± 11.6
HR (bpm) 75.5 ± 13.2 72.6 ± 13.1
Waist-Hip ratio 0.89 ± 0.03 0.88 ± 0.05
TC (mmol/L) 5.13 ± 0.24 5.11 ± 0.22
TG (mmol/L) 1.54 ± 0.32 1.57 ± 0.30
LDL (mmol/L) 3.36 ± 0.41 3.40 ± 0.36
HDL (mmol/L) 0.93 ± 0.06 0.92 ± 0.06
Lp(a) (mg/L) 238.96 ± 26.45 244.35 ± 33.15
ApoA1 (mmol/L) 1.06 ± 0.33 1.05 ± 0.29
ApoB (mmol/L) 1.10 ± 0.26 1.11 ± 0.30
FPG (mmol/L) 5.3 ± 0.6 5.4 ± 0.5
HbA1c (%) 5.9 ± 0.8 5.8 ± 0.6
Hs-CRP (mg/L) 10.7 ± 3.5 11.4 ± 3.2
Hypertension (%) 36 (26.1) 18 (28.1)
Diabetes (%) 19 (13.8) 10 (15.6)
CHD (%) 25 (18.1)* 15 (23.4)
Intracranial hemorrhage (%) 0 (0) 0 (0)
Gastrointestinal bleeding (%) 5 (3.6)* 0 (0)
HP infection (%) 12 (8.7)* 3 (4.7)
Statins (%) 127 (92.0) 60 (93.8)
Anti-hypertension (%) 27 (19.6) 11 (17.2)
Anti-diabetes (%) 15 (10.9) 8 (12.5)
  1. Denote: * P < 0.05 versus without aspirin group